Global health status and fatigue score in isocitrate dehydrogenase-mutant diffuse glioma grades 2 and 3: A longitudinal population-based study from surgery to 12-month follow-up.

Tomás Gómez Vecchio Isabelle Rydén Anneli OzanneMalin BlomstrandLouise Carstam Anja Smits Asgeir Store Jakola

Published in: Neuro-oncology practice (2024)

Deterioration beyond MCID was seen in approximately one-third of patients. Changes in global health status could not be predicted, but changes in fatigue may be influenced by tumor-targeted and symptomatic treatment.

Keyphrases

global health
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
minimally invasive
public health
sleep quality
coronary artery bypass
low grade
physical activity
atrial fibrillation
patient reported
replacement therapy